the Bioinformatics Market size in Latin America was worth USD 1.31 billion in 2022 and estimated to be growing at a CAGR of 16.2% to reach USD 2.78 billion by 2027. Latin America is deemed to have significant growth opportunities in the coming years. Factors like increasing funds and growing demand for protein and nucleic acid sequencing are escalating the market demand. The increasing research in genomics and proteomics research are some factors driving the growth of this region.
Bioinformatics is a field of study in which biological data is interpreted using and developing new software methods and tools. It is an interdisciplinary field with engineering, computer science, mathematics, and statistics to explain the biological information acquired. Bioinformatics has of all the biological studies which are carried out by using computer programming. Bioinformatics is fundamentally utilized for understanding candidate genes and single nucleotide polymorphisms.
Bioinformatics has its application in a lot of areas in biology. It provides useful information in gene ontology to name and organize data. In experimental molecular biology, it helps the form of techniques such as image and signal processing. The field of genomics and genetics assists in sequencing genomes and noting their mutations. It helps understand the evolutionary aspects of molecular biology by comparing the obtained genetic and genomic data. It is also used in analyzing gene and protein expression and regulation.
The Latin American Bioinformatics market is driven by the rising need for integrated bioinformatics systems in proteomics and genomics, the growing requirement for sequencing protein and nucleic acids, the increasing help of this field in producing new medicines and clinical diagnostics, increasing initiatives from the government and increasing number of partnerships between research organizations and companies among others.
A few factors which limit this market are lack of user-friendly tools, high costs, lack of skilled workers, and lack of interoperability among various data formats.
This research report on the Latin America Bioinformatics Market has been segmented & sub-segmented into the following categories:
By Sector:
By-Products and Services:
By Application:
By Country:
Regionally, the Latin American Bioinformatics market in this region is still in the nascent stages. However, factors such as increased funding, growing demand for protein and nucleic acid sequencing, and increasing research in genomics and proteomics research drive the growth of this market in the region.
The Brazilian bioinformatics market accounts for the largest share in the Latin American bioinformatics market, with 40% of the share by a growing number of training and development programs, which tends to increase bioinformatics tools by industrial and academic in life sciences research. The share is also attributed to the high concentration of bioinformatics research institutes, augmenting indigenous and global bioinformatics players' concentration.
The Mexican bioinformatics market is projected to witness steady growth to produce profitable outcomes during the period. This country is predicted to have 20% of the share as increasing help in manufacturing new medicines and clinical diagnostics and growing initiatives from government and other research organizations.
Bioinformatics markets in Chile and Peru are estimated to have the highest growth during the analysis period. The increase in these two countries is due to the nations' initiatives relevant to researchers' skills and development, also continuous collaborations to advance the acquisition of bioinformatics in life sciences research.
KEY MARKET PLAYERS:
Companies playing a significant role in the Latin American Bioinformatics Market profiled in this report are Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc., and Waters Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Sector
5.1.1 Animal Biotechnology
5.1.2 Environmental Biotechnology
5.1.2.1 Alternative Energy Sources
5.1.2.2 Waste Clean-Up/Bioremediation
5.1.2.3 Climate Change Studies
5.1.3 Agricultural Biotechnology
5.1.3.1 Crop Yield Improvement
5.1.3.2 Pest Resistance
5.1.3.3 Improvement of Plant Resistance
5.1.3.4 Biodiversity Informatics
5.1.3.5 Nutritional Quality Improvement
5.1.4 Forensic Biotechnology
5.1.5 Medical Biotechnology
5.1.5.1 Drug Development
5.1.5.2 Clinical Diagnostics
5.1.5.3 Molecular Medicine
5.1.5.3.1 Personalized Medicine
5.1.5.3.2 Preventive Medicine
5.1.5.4 Gene Therapy
5.1.5.5 Reproductive Biotechnology
5.1.6 Academics
5.1.7 Other sectors
5.1.8 Y-o-Y Growth Analysis, By Sector
5.1.9 Market Attractiveness Analysis, By Sector
5.1.10 Market Share Analysis, By Sector
5.2 Products and Services
5.2.1 Bioinformatics Platforms
5.2.1.1 Sequence Analysis Platforms
5.2.1.2 Sequence Alignment Platforms
5.2.1.3 Sequence Manipulation Platforms
5.2.1.4 Structural and Functional Analysis Platforms
5.2.1.5 Other Bioinformatics Platforms
5.2.2 Knowledge Management Tools
5.2.2.1 Generalized Knowledge Management Tools
5.2.2.2 Specialized Knowledge Management Tools
5.2.3 Bioinformatics Services
5.2.3.1 Data Analysis
5.2.3.2 Sequencing Services
5.2.3.3 Other Bioinformatics Services
5.2.3.4 Database and Management Services
5.2.4 Y-o-Y Growth Analysis, By Products and Services
5.2.5 Market Attractiveness Analysis, By Products and Services
5.2.6 Market Share Analysis, By Products and Services
5.3 Application
5.3.1 Proteomics
5.3.2 Transcriptomics
5.3.3 Molecular Phylogenetics
5.3.4 Chemoinformatics
5.3.5 Drug Design and Genomics
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Sector
6.1.3.2 By Products and Services
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Sector
6.1.4.2 By Products and Services
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Sector
6.1.5.2 By Products and Services
6.1.5.3 By Application
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Affymetrix Inc.
8.3 Applied Biological Materials (ABM)
8.4 3rd Millenium Inc.
8.5 Illumina Inc.,
8.6 Thermo Fisher Scientific Inc.
8.7 Qiagen N.V.
8.8 Biomax Informatics Ag
8.9 DNAnexus, Inc.
8.10 Waters Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
